EtoMideate: Key Ingredients and Absorption Rate Explained
Key Ingredients of EtoMideate
EtoMideate is classified as a general anesthetic and has been designated as a controlled substance, leading to stricter management. Due to joint measures by the Ministry of Food and Drug Safety (MFDS) and customs authorities, its supply is expected to be discontinued. It is a highly addictive drug that can cause physical abnormalities with just one dose.
The primary ingredient of EtoMideate has been confirmed as 'etomidate,' a general anesthetic used in medical settings. However, during illegal importation and distribution, additives or modifications may have been introduced, making precise ingredient analysis complex. The MFDS is conducting additional tests to clearly distinguish between medically approved etomidate and illegally imported EtoMideate.

Absorption Rate of EtoMideate
The specific absorption rate of EtoMideate has not been confirmed in available data. However, due to its distribution as an e-liquid for electronic cigarettes, it is believed to be rapidly absorbed. One use can immediately trigger neurological responses, requiring caution.
When inhaled through electronic cigarettes, EtoMideate is quickly absorbed from the lungs into the bloodstream. This leads to immediate anesthesia effects and is one reason for its increasing use among younger demographics. Experts warn that due to its rapid absorption rate, it can cause severe physical abnormalities within a short time.
Reasons Behind EtoMideate's Classification as a Controlled Substance
On August 12, 2025, the MFDS announced that EtoMideate would be classified as a general anesthetic and designated as a controlled substance. This was due to reports of 'EtoMideate,' referred to as the 'second propofol,' being hidden in e-cigarette liquids, with 32 cases of arrests reported.
Due to illegal importation incidents involving EtoMideate in electronic cigarette form, police conducted a concentrated crackdown on August 20, 2026, arresting 32 members of distribution networks. Known as 'zombie e-cigarettes,' it is an addictive drug that can cause physical abnormalities with just one puff.
Before EtoMideate was classified as a controlled substance in April 2025, the MFDS announced a supply discontinuation notice on April 23, 2025, due to increasing cases of misuse of medically approved etomidate. Subsequently, customs authorities declared an all-out effort to block EtoMideate imports at borders, officially announcing enhanced enforcement starting February 3, 2026.
Difference Between EtoMideate and Propofol
EtoMideate is referred to as the 'second propofol,' sharing similar anesthetic effects with propofol but differing in absorption rate and addiction potential. Propofol is used medically, while EtoMideate is a new type of drug distributed through illegal importation.
Propofol is administered intravenously for anesthesia, whereas EtoMideate is inhaled as an e-liquid. This makes EtoMideate's absorption rate faster than propofol and its addictive potential stronger. Additionally, propofol is used under medical supervision, while EtoMideate has seen misuse due to illegal importation.
Case Study: Singapore Traffic Accidents
On July 15, 2026, seven consecutive traffic accidents in Singapore were prosecuted due to the use of EtoMideate. This case highlights the dangers of driving under the influence of anesthetic drugs.
Singapore police emphasized EtoMideate's addictive nature and its risks while driving through this incident. The case brought global attention to issues surrounding EtoMideate distribution and misuse.
EtoMideate is classified as a general anesthetic but has seen misuse outside medical purposes, leading to expected supply discontinuation due to MFDS regulations. Customs authorities and police are strengthening enforcement to block illegal importation at borders.
Distribution Methods of EtoMideate
EtoMideate is distributed hidden within e-liquid containers for electronic cigarettes. This form became quite widespread before its classification as a controlled substance, particularly increasing among younger demographics.
Illegally imported EtoMideate is primarily exported from Asian regions, often passing through Singapore and Malaysia to reach South Korea. Customs authorities are strengthening international cooperation to identify these smuggling routes.
The MFDS announced an expected supply discontinuation for EtoMideate on April 23, 2025, after which customs authorities declared an all-out border blockade effort against the substance known as 'zombie e-cigarettes.' On February 3, 2026, customs began officially announcing enhanced enforcement against EtoMideate smuggling, followed by a further notice on February 4 regarding the border blockade campaign.
Addictive Potential of EtoMideate
EtoMideate is a highly addictive drug that can cause physical abnormalities with just one puff. It has been reported to cause symptoms such as 'walking like a zombie,' increasing risks, especially while driving.
According to addiction research, neurological abnormalities may occur within 10 minutes of use, potentially leading to severe breathing difficulties or loss of consciousness. The increase in younger demographic usage has also led to rising addiction cases.
The MFDS began announcing EtoMideate's classification as a controlled substance on August 14, 2025, and on January 23, 2026, announced enhanced pharmacy management measures. These actions were taken following numerous misuse cases that drew criticism during parliamentary hearings.
Legal Judgments Related to EtoMideate
The Supreme Court issued a four-year prison sentence for illegal administration and sale of 'second propofol' on March 27, 2026. This marks the first large-scale legal case following EtoMideate's classification as a controlled substance.
On August 20, 2026, police conducted a concentrated crackdown, arresting 32 individuals involved in illegal importation of EtoMideate in electronic cigarette form. This demonstrates ongoing enforcement efforts six months after the drug was classified as a controlled substance.
Risks and Response Measures for EtoMideate
EtoMideate is classified as a general anesthetic but poses serious risks when misused, particularly increasing traffic accident risks while driving. Caution is necessary in such cases.
The MFDS and customs authorities are jointly implementing measures to discontinue supply and block illegal importation. Efforts continue to provide a safe medical environment for the public. Additionally, educational programs aim to reduce misuse among younger demographics.
FAQ on EtoMideate
Q: What is the primary ingredient of EtoMideate?
A: The primary ingredient has not been confirmed in available data; it is classified as a general anesthetic.
Q: How fast is EtoMideate absorbed?
A: Specific absorption rate information is not provided in the available data.
Q: What distinguishes EtoMideate from propofol?
A: EtoMideate is referred to as the 'second propofol,' differing from propofol in terms of addiction potential and absorption rate.
Further research is needed on EtoMideate's ingredients and absorption rate. Please refer to official announcements by customs authorities and the MFDS for more information.
You can view similar articles in one place.
View Related ArticlesFAQ
What is the primary ingredient of EtoMideate?
The primary ingredient has not been confirmed in available data; it is classified as a general anesthetic.
How fast is EtoMideate absorbed?
Specific absorption rate information is not provided in the available data.
What distinguishes EtoMideate from propofol?
EtoMideate is referred to as the 'second propofol,' differing from propofol in terms of addiction potential and absorption rate.
Korean Source
This article is an English localization of a Korean-language report from BlogScore. Original: 에토미데이트 주 성분과 흡수 속도 설명